GRETO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 3.872
EU - Europa 1.671
AS - Asia 550
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.095
Nazione #
US - Stati Uniti d'America 3.862
PL - Polonia 540
IE - Irlanda 353
IT - Italia 341
HK - Hong Kong 254
SE - Svezia 221
CN - Cina 154
JO - Giordania 80
DE - Germania 59
RU - Federazione Russa 41
FI - Finlandia 34
GB - Regno Unito 26
SG - Singapore 21
VN - Vietnam 17
IN - India 16
CH - Svizzera 13
ES - Italia 13
FR - Francia 13
CA - Canada 10
UA - Ucraina 9
BE - Belgio 4
TR - Turchia 4
LT - Lituania 2
UZ - Uzbekistan 2
AU - Australia 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
NL - Olanda 1
TH - Thailandia 1
Totale 6.095
Città #
Fairfield 637
Warsaw 540
Chandler 380
Ashburn 374
Dublin 351
Seattle 294
Woodbridge 277
Cambridge 271
Houston 231
Wilmington 210
Hong Kong 184
Dearborn 131
Lawrence 119
Altamura 108
Princeton 90
Beijing 87
Florence 76
Ann Arbor 75
Buffalo 61
New York 50
Medford 45
Boston 42
Moscow 38
San Diego 38
Shanghai 24
Boardman 19
Falls Church 18
West Jordan 18
Barcelona 13
Pune 13
Rome 13
Bern 12
Dong Ket 11
Jacksonville 10
Munich 10
Nanjing 9
Norwalk 9
Guangzhou 7
Hillsboro 7
Toronto 7
Redwood City 6
London 5
Milan 5
Phoenix 5
Prato 5
Redmond 5
Andover 4
Brussels 4
Hefei 4
Kunming 4
Paris 4
Singapore 4
Bergamo 3
Falkenstein 3
Frankfurt am Main 3
Fremont 3
Helsinki 3
Kilburn 3
Mcallen 3
Montemurlo 3
Nagold 3
Nürnberg 3
Pistoia 3
Salerno 3
Wandsworth 3
Bojano 2
Busto Arsizio 2
Calgary 2
Chicago 2
Chongqing 2
Empoli 2
Ferrara 2
Fuzhou 2
Izmir 2
Los Angeles 2
Nantes 2
Novate Milanese 2
Pelago 2
Romainville 2
Saint-Fons 2
San Francisco 2
San Mateo 2
Santa Clara 2
Santa Maria A Monte 2
Scarperia e San Piero 2
Somma Vesuviana 2
Southwark 2
Tashkent 2
Vilnius 2
Washington 2
Wuhan 2
Zaozhuang 2
Zhengzhou 2
Acton 1
Aprilia 1
Berlin 1
Bologna 1
Bracknell 1
Brentford 1
Brescia 1
Totale 5.066
Nome #
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 211
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 205
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 179
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 154
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 114
Influence of age and subtype in outcome of operable liposarcoma 114
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 113
TomoTherapy treatments of multiple brain lesions: an in-phantom accuracy evaluation 111
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 111
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 110
Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting 108
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 102
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 98
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 96
Radiotherapy in the age of cancer immunology: Current concepts and future developments 96
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 96
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 95
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 94
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 93
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 91
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 89
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 88
Doxorubicin and cyclophosphamideversus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvantchemotherapy in breast cancer. 87
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 85
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 85
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 85
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen. 84
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 84
Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature 84
Intercomparison Study On Small Field Output Factor Measurements 83
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 82
Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis during Radiotherapy for Head and Neck Cancer 82
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 81
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 81
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 79
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 79
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 79
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experience. 78
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 77
Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases. 77
Radiomic and dosiomic profiling of paediatric medulloblastoma tumours treated with intensity modulated radiation therapy 77
A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis 76
Soft tissue myxofibrosarcoma: A clinico-pathological analysis of a series of 75 patients with emphasis on the epithelioid variant 75
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 74
Leiomyosarcoma: Clinicopathological study and retrospective analysis of prognostic factors in a series of 100 patients 73
Methodological approach to create an atlas using a commercial auto-contouring software 72
Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach. 71
Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University. 71
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 70
Impact of sentinel node tumor burden on outcome of invasive breast cancer patients. 70
PO-0873: 2D pixelated diamond detector for patient QA in advanced radiotherapy treatments 69
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 65
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO) 65
Prognostic impact of nodal relapse in definitive prostate-only irradiation 64
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 64
Neoadjuvant treatment of soft tissue sarcoma: A single center experience 63
Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution 62
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 62
GammaTools: A modular multifunction phantom for quality assurance in GammaKnife treatments 57
Clinical features, prognostic factors and outcome in a series of 29 extra-skeletal Ewing Sarcoma. Adequate margins and surgery-radiotherapy association improve overall survival 55
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 55
Prostate cancer as a paradigm of multidisciplinary approach? highlights from the italian young radiation oncologist meeting 51
Clinical validation of an automatic atlas-based segmentation tool for male pelvis CT images 48
Impact of COVID-19 on workload burden of a complex radiotherapy facility 43
Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity 42
Ewing family tumors of the appendicular skeleton: a retrospective analysis of prognostic factors 42
Treatment options in femoral radiation fractures following soft tissue sarcoma: Incidence, risk factors, failures and flowchart of treatment 39
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 38
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 36
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 34
Regorafenib in glioblastoma recurrence: A case report 31
CONFORMAL RADIOTHERAPY (3DCRT) TO ATTEMPT RADICAL plus CHEMOTHERAPY +/- SURGERY IN THE TREATMENT OF EWING'S SARCOMA (EWS) BASED ON THE PELVIC AREA 31
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 30
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 29
Clinical outcomes and secondary glaucoma after gamma-knife radiosurgery and Ruthenium-106 brachytherapy for uveal melanoma: a single institution experience 29
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery 29
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 25
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature 21
Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings 19
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 16
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 16
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 15
PAIDEIA: pacemaker and implanted cardioverter defibrillator management in radiation therapy—a survey by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 14
Brief report: pediatric high-grade gliomas treated with vinorelbine and valproic acid added to temozolomide 13
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 12
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 11
Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review 11
Single-fraction radiotherapy (SFRT) for bone metastases: Patient selection and perspectives 10
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 9
Radiation treatment for adult rare cancers: Oldest and newest indication 9
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 9
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 8
Evaluation of Italian radiotherapy research from 1985 to 2005: preliminary analysis 7
Radiomic- and dosiomic-based clustering development for radio-induced neurotoxicity in pediatric medulloblastoma 3
Totale 6.230
Categoria #
all - tutte 21.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.616


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019500 0 0 0 0 0 0 0 0 0 104 204 192
2019/20201.588 93 69 26 121 224 246 229 182 163 112 103 20
2020/2021693 69 46 28 124 30 40 46 45 74 83 61 47
2021/2022532 11 26 42 25 20 28 16 54 31 23 86 170
2022/20231.643 129 369 87 74 115 278 209 111 189 3 56 23
2023/2024756 31 63 99 33 66 131 36 229 15 53 0 0
Totale 6.230